News - Gilde Healthcare


ProVerum raises €30M in Series A funding led by Gilde Healthcare & Lightstone Ventures

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor’s office, today announced the closing of a €30 million Series A equity financing led by Gilde Healthcare Partners and Lightstone Ventures, including participation from existing investors. ProVerum has developed a novel treatment solution for patients with symptomatic BPH designed...
January 11, 2022
These were all messages